Recent News
On December 24, 2025 the company received a consensus analyst recommendation of “Hold,” with broker price-target revisions noted in the coverage update. Other headlines in the trailing 13-week window focused on analyst coverage and target changes rather than new corporate initiatives or material transactions.
Technical Analysis
Directional Indicators (ADX / DI+ / DI-): ADX reads 21.11, signaling an emerging trend; DI+ stands at 30.77 and shows an increasing trend while DI- peaked and reversed at 18.10, which supports a bullish directional bias and aligns with the constructive short-term momentum.
MACD: MACD equals 0.56 with the signal line at 0.35 and the MACD trend labeled increasing; the MACD currently sits above its signal line, which presents a bullish momentum confirmation for the immediate outlook.
MRO (Momentum/Regression Oscillator): MRO registers a small positive reading of 8.29 with a decreasing trend; that positive but modest level indicates price sits slightly above the model target and signals limited short-term extension risk, increasing the probability of near-term consolidation rather than a steep continuation.
RSI: RSI at 55.86 with an increasing trend indicates steady bullish momentum without overbought stress, supporting the idea of continued range-biased gains rather than an abrupt reversal.
Price vs. Moving Averages & Bands: The latest close of $31.91 sits above the 12-day EMA ($30.43, increasing), the 20-day average ($30.16), the 50-day average ($29.05) and near the 200-day average ($30.90). Price currently trades between the 1x and 2x upper Bollinger band levels (upper 1x = $31.12; upper 2x = $32.09), which signals short-term extension toward the upper band but also the potential for pullback toward short-term averages if momentum eases.
Ichimoku / SuperTrend / Volume: Tenkan-sen at 30.59 with Kijun-sen at 29.98 supports the short-term bullish disposition; the super trend lower read of 30.11 provides a structural short-term support reference. Daily volume (58,143) exceeds the 10-day average (46,572), lending conviction to the recent move without showing extreme breadth.
Fundamental Analysis
Earnings & Surprise: For the quarter ending 2025-12-31 (report dated 2026-01-26) reported EPS equaled $0.91 versus an estimate of $0.79, generating a positive EPS surprise of approximately 15.19%. The outperformance occurred alongside reported revenue strength for the period, supporting near-term confidence in reported results.
Profitability & Growth Rates: Reported earnings growth sits at 26.39% (overall earningsGrowth), while earnings growth QoQ shows -272.55% and earnings growth YoY shows -33.01%; these labeled QoQ and YoY values reflect sizeable quarter-to-quarter and year-over-year variability in the reported series. Revenue growth overall registers 3.68%, with QoQ revenue growth at 83.28% and revenue growth YoY at -81.22%, indicating large timing effects and lumpiness across the compared periods.
Valuation Multiples: Trailing PE stands at 32.05, which sits below the industry peer mean of approximately 58.43 but above the industry peer median of about 28.20. Forward PE equals 31.90. The PEG ratio reads 1.21, which compares above the industry peer mean reported for the peer set; the PEG QoQ change shows a negative adjustment of about -142.49% in the labeled field.
Capital & Funding Metrics: Invested capital shows $-198,100,000 (negative) per the provided figure; cost of debt registers 28.64%. Cash-flow-to-earnings shows 0.0 in the provided metric. These items indicate funding and capital dynamics that warrant monitoring on subsequent reports.
WMDST Valuation Summary: The current valuation as determined by WMDST rates the stock as fair-valued, with reported earnings upside in the latest quarter offset by variability in growth metrics and capital measures.
MOST-RECENT QUARTERLY REPORT
| REPORT PERIOD ENDING: | 2025-12-31 |
| REPORT DATE: | 2026-01-26 |
| NEXT REPORT DATE: | 2026-04-27 |
| CASH FLOW | Begin Period Cash Flow | — |
| Operating Cash Flow | — | |
| Capital Expenditures | — | |
| Change In Working Capital | — | |
| Dividends Paid | — | |
| Cash Flow Delta | — | |
| End Period Cash Flow | — | |
| INCOME STATEMENT | REVENUE | |
| Total Revenue | — | |
| Forward Revenue | — | |
| COSTS | ||
| Cost Of Revenue | — | |
| Depreciation | — | |
| Depreciation and Amortization | — | |
| Research and Development | — | |
| Total Operating Expenses | — | |
| PROFITABILITY | ||
| Gross Profit | — | |
| EBITDA | — | |
| EBIT | — | |
| Operating Income | — | |
| Interest Income | — | |
| Interest Expense | — | |
| Net Interest Income | — | |
| Income Before Tax | — | |
| Tax Provision | — | |
| Tax Rate | — | |
| Net Income | — | |
| Net Income From Continuing Operations | — | |
| EARNINGS | ||
| EPS Estimate | $ 0.79 | |
| EPS Actual | $ 0.91 | |
| EPS Difference | $ 0.12 | |
| EPS Surprise | 15.19 % | |
| Forward EPS | $ 0.91 | |
| BALANCE SHEET | ASSETS | |
| Total Assets | — | |
| Intangible Assets | — | |
| Net Tangible Assets | — | |
| Total Current Assets | — | |
| Cash and Short-Term Investments | — | |
| Cash | — | |
| Net Receivables | — | |
| Inventory | — | |
| Long-Term Investments | — | |
| LIABILITIES | ||
| Accounts Payable | — | |
| Short-Term Debt | — | |
| Total Current Liabilities | — | |
| Net Debt | — | |
| Total Debt | — | |
| Total Liabilities | — | |
| EQUITY | ||
| Total Equity | — | |
| Retained Earnings | — | |
| VALUATION & PER-SHARE METRICS | EQUITY & PER-SHARE METRICS | |
| Book Value Per-Share | — | |
| Shares Outstanding | — | |
| Revenue Per-Share | — | |
| VALUATION | Market Capitalization | — |
| Enterprise Value | — | |
| Enterprise Multiple | — | |
| Enterprise Multiple QoQ | — | |
| Enterprise Multiple YoY | — | |
| Enterprise Multiple IPRWA | — | |
| EV/R | — | |
| CAPITAL STRUCTURE | ||
| Asset To Equity | — | |
| Asset To Liability | — | |
| Debt To Capital | — | |
| Debt To Assets | — | |
| Debt To Assets QoQ | — | |
| Debt To Assets YoY | — | |
| Debt To Assets IPRWA | — | |
| Debt To Equity | — | |
| Debt To Equity QoQ | — | |
| Debt To Equity YoY | — | |
| Debt To Equity IPRWA | — | |
| PRICE-BASED VALUATION | ||
| Price To Book (P/B) | — | |
| Price To Book QoQ | — | |
| Price To Book YoY | — | |
| Price To Book IPRWA | — | |
| Price To Earnings (P/E) | 32.052 | |
| Price To Earnings QoQ | -26.692 % | |
| Price To Earnings YoY | 6.06 % | |
| Price To Earnings IPRWA | high: 90.392 mean: 58.426 CBNK: 32.052 median: 28.198 low: 27.354 |
|
| PE/G Ratio | 1.215 | |
| Price To Sales (P/S) | — | |
| Price To Sales QoQ | — | |
| Price To Sales YoY | — | |
| Price To Sales IPRWA | — | |
| FORWARD MULTIPLES | ||
| Forward P/E | 31.899 | |
| Forward PE/G | 1.209 | |
| Forward P/S | — | |
| EFFICIENCY | OPERATIONAL | |
| Operating Leverage | — | |
| ASSET & SALES | ||
| Asset Turnover Ratio | — | |
| Asset Turnover Ratio QoQ | — | |
| Asset Turnover Ratio YoY | — | |
| Asset Turnover Ratio IPRWA | — | |
| Receivables Turnover | — | |
| Receivables Turnover Ratio QoQ | — | |
| Receivables Turnover Ratio YoY | — | |
| Receivables Turnover Ratio IPRWA | — | |
| Inventory Turnover | — | |
| Inventory Turnover Ratio QoQ | — | |
| Inventory Turnover Ratio YoY | — | |
| Inventory Turnover Ratio IPRWA | — | |
| Days Sales Outstanding (DSO) | — | |
| CASH CYCLE | ||
| Cash Conversion Cycle Days (CCC) | — | |
| Cash Conversion Cycle Days QoQ | — | |
| Cash Conversion Cycle Days YoY | — | |
| Cash Conversion Cycle Days IPRWA | — | |
| CAPITAL DEPLOYMENT | ||
| Cash Conversion Ratio | — | |
| CapEx To Revenue | — | |
| CapEx To Depreciation | — | |
| CAPITAL, LIQUIDITY & COVERAGE | CAPITAL STRUCTURE | |
| Total Capital | — | |
| Net Invested Capital | — | |
| Invested Capital | $ -198.10 M | |
| Net Tangible Assets | — | |
| Net Working Capital | — | |
| LIQUIDITY | ||
| Cash Ratio | — | |
| Current Ratio | — | |
| Current Ratio QoQ | — | |
| Current Ratio YoY | — | |
| Current Ratio IPRWA | — | |
| Quick Ratio | — | |
| Quick Ratio QoQ | — | |
| Quick Ratio YoY | — | |
| Quick Ratio IPRWA | — | |
| COVERAGE & LEVERAGE | ||
| Debt To EBITDA | — | |
| Cost Of Debt | 28.643 % | |
| Interest Coverage Ratio | — | |
| Interest Coverage Ratio QoQ | — | |
| Interest Coverage Ratio YoY | — | |
| Interest Coverage Ratio IPRWA | — | |
| Operating Cash Flow Ratio | — | |
| TIMING / LIQUIDITY | ||
| Days Payables Outstanding (DPO) | — | |
| DIVIDENDS | ||
| Dividend Coverage Ratio | — | |
| Dividend Payout Ratio | — | |
| Dividend Rate | — | |
| Dividend Yield | — | |
| PERFORMANCE | GROWTH | |
| Asset Growth Rate | — | |
| Revenue Growth | 3.682 % | |
| Revenue Growth QoQ | 83.275 % | |
| Revenue Growth YoY | -81.219 % | |
| Revenue Growth IPRWA | high: 11.371 % CBNK: 3.682 % mean: 1.267 % median: -0.957 % low: -2.627 % |
|
| Earnings Growth | 26.389 % | |
| Earnings Growth QoQ | -272.545 % | |
| Earnings Growth YoY | -33.013 % | |
| Earnings Growth IPRWA | high: 36.957 % CBNK: 26.389 % mean: -6.59 % median: -18.571 % low: -18.987 % |
|
| MARGINS | ||
| Gross Margin | — | |
| Gross Margin QoQ | — | |
| Gross Margin YoY | — | |
| Gross Margin IPRWA | — | |
| EBIT Margin | — | |
| EBIT Margin QoQ | — | |
| EBIT Margin YoY | — | |
| EBIT Margin IPRWA | — | |
| Return On Sales (ROS) | — | |
| Return On Sales QoQ | — | |
| Return On Sales YoY | — | |
| Return On Sales IPRWA | — | |
| CASH FLOW | ||
| Free Cash Flow (FCF) | — | |
| Free Cash Flow Yield | — | |
| Free Cash Flow Yield QoQ | — | |
| Free Cash Flow Yield YoY | — | |
| Free Cash Flow Yield IPRWA | — | |
| Free Cash Growth | — | |
| Free Cash Growth QoQ | — | |
| Free Cash Growth YoY | — | |
| Free Cash Growth IPRWA | — | |
| Free Cash To Net Income | — | |
| Cash Flow Margin | — | |
| Cash Flow To Earnings | 0.0 | |
| VALUE & RETURNS | ||
| Economic Value Added | — | |
| Return On Assets (ROA) | — | |
| Return On Assets QoQ | — | |
| Return On Assets YoY | — | |
| Return On Assets IPRWA | — | |
| Return On Capital Employed (ROCE) | — | |
| Return On Equity (ROE) | — | |
| Return On Equity QoQ | — | |
| Return On Equity YoY | — | |
| Return On Equity IPRWA | — | |
| DuPont ROE | — | |
| Return On Invested Capital (ROIC) | — | |
| Return On Invested Capital QoQ | — | |
| Return On Invested Capital YoY | — | |
| Return On Invested Capital IPRWA | — | |